Lisata Therapeutics (LSTA) Accumulated Depreciation & Amortization (2016 - 2025)
Lisata Therapeutics (LSTA) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $472000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Accumulated Depreciation & Amortization fell 16.46% year-over-year to $472000.0, compared with a TTM value of $472000.0 through Sep 2025, down 16.46%, and an annual FY2024 reading of $589000.0, up 211.64% over the prior year.
- Accumulated Depreciation & Amortization was $472000.0 for Q3 2025 at Lisata Therapeutics, down from $589000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $589000.0 in Q4 2024 and bottomed at $189000.0 in Q4 2023.
- Average Accumulated Depreciation & Amortization over 3 years is $464500.0, with a median of $493500.0 recorded in 2024.
- The sharpest move saw Accumulated Depreciation & Amortization soared 211.64% in 2024, then dropped 16.46% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $189000.0 in 2023, then skyrocketed by 211.64% to $589000.0 in 2024, then decreased by 19.86% to $472000.0 in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for LSTA at $472000.0 in Q3 2025, $589000.0 in Q4 2024, and $565000.0 in Q3 2024.